Research is going everywhere throughout the world, for a vaccine to battle the consistently developing danger of Coronavirus. A few immunizations have entered the last phases of testing, including the antibodies being created by Oxford University, Novavax and even Moderna.
India is also developing few vaccines, out of which two have entered human preliminaries.
As indicated by the most recent reports, an immunization will be accessible by right on time one year from now, at the most recent. In the event that we are sufficiently fortunate, we may see one before the current year’s over.
The Serum Institute of India, the world’s biggest producer of antibodies by volume, has hit manages both Oxford University and Novavax to fabricate and gracefully their immunization in India and other low-to-direct salary nations. It said that at any rate 100 million portions, of conceivably billions that it intends to deliver, would be made accessible for as low as Rs. 240, and if conceivable, lesser, per portion. This low cost would be empowered through another US$ 150 million financing it is accepting from the Bill and Melinda Gates Foundation.
